Vaksin Covid-19 Janssen: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
RaFaDa20631 (bicara | kontrib) k RaFaDa20631 memindahkan halaman Vaksin COVID-19 Johnson & Johnson ke Vaksin Covid-19 Janssen: produsen yang sebenarnya adalah Janssen yang merupakan anak perusahaan J&J |
k →top: clean up |
||
(Satu revisi perantara oleh satu pengguna lainnya tidak ditampilkan) | |||
Baris 40:
| legal_UK_comment =
| legal_US = Tak disepakati
| legal_US_comment = ([[Otorisasi Pemakaian Darurat]])<ref name="Janssen COVID-19 Vaccine FDA
| legal_EU = Otorisasi pemasaran kondisional diberikan
| legal_EU_comment = <ref name="COVID-19 Vaccine Janssen EPAR">{{cite web | title=COVID-19 Vaccine Janssen EPAR | website=[[European Medicines Agency]] (EMA) | date=5 March 2021 | url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen | access-date=16 March 2021}}</ref>
Baris 70:
<!-- Chemical and physical data -->}}
{{COVID-19 pandemic sidebar|expanded=medis}}
'''Vaksin COVID-19 Johnson & Johnson''' adalah [[vaksin COVID-19]] [[vektor viral]] [[Adenoviridae|adenovirus]] manusia<ref name="ensemble" /> yang dikembangkan oleh [[Janssen Vaccines]] di [[Leiden]], Belanda,<ref>{{Cite web|url=https://nltimes.nl/2021/02/16/leiden-developed-covid-19-vaccine-submitted-ema-approval|title=Leiden developed Covid-19 vaccine submitted to EMA for approval|date=2021-02-16}}</ref> dan perusahaan induknya di Belgia [[Janssen Pharmaceuticals]],<ref>{{Cite web|title=Clinical trial COVID-19 vaccine candidate underway|url=https://www.janssen.com/belgium/clinical-trial-covid-19-vaccine-candidate-underway|access-date=2021-03-13|website=Janssen Belgium|language=en}}</ref> subsidier dari perusahaan Amerika Serikat [[Johnson & Johnson]] (J&J).<ref>{{Cite web|url=https://nltimes.nl/2021/03/11/ema-recommends-johnson-johnson-covid-vaccine-approval-developed-leiden|title=EMA recommends Johnson & Johnson Covid vaccine for approval; Developed in Leiden|publisher=NL Times}}</ref><ref name="Globe 20200312">{{cite news|url=https://www.bostonglobe.com/2020/03/12/business/beth-israel-is-working-with-johnson-johnson-coronavirus-vaccine/|title=Beth Israel is working with Johnson & Johnson on a coronavirus vaccine|work=The Boston Globe|date=12 March 2020|first=Jonathan |last=Saltzman | name-list-style=vanc}}</ref>
Vaksin tersebut berbahan dasar adenovirus manusia yang dimodifikasi untuk membuat gen untuk menciptakan [[spike protein]] terhadap virus [[SARS-CoV-2]] yang menyebabkan COVID-19.<ref name="Janssen CMA application" /> Vaksin tersebut hanya diwajibkan satu dosis dan tak perlu disimpan beku.<ref name="Fact sheet" />
Baris 90:
[[Kategori:Adenoviridae]]
[[Kategori:Janssen Pharmaceutica]]
[[Kategori:Johnson & Johnson]]
|